Expansion of melanoma-specific T cells from lymph nodes of patients in stage III: Implications for adoptive immunotherapy in treating cancer

Surgery (United States)

Volumn 152, Issue 4, 2012, Pages 557-566

  Visioni, Anthony ^a   Zhang, Mei ^b   Graor, Hallie ^a   Kim, Julian ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Case Western Reserve University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 7; MELANOMA ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL GROWTH; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE; LYMPH NODE DISSECTION; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; T LYMPHOCYTE;

APOPTOSIS; CELL CULTURE TECHNIQUES; CRYOPRESERVATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; INTERLEUKIN-7; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; T-LYMPHOCYTES;

EID: 84867048581     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.07.002     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. C.M. Balch, J.E. Gershenwald, S.J. Soong, and J.F. Thompson Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate J Surg Oncol 104 2011 379 385
3. A. Jemal, M. Saraiya, and P. Patel Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006 J Am Acad Dermatol 65 Suppl 1 2011 S17 S25 e11-3
4. M.B. Atkins, L. Kunkel, M. Sznol, and S.A. Rosenberg High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update Cancer J Sci Am 6 Suppl 1 2000 S11 S14
5. M.E. Dudley, J.C. Yang, and R. Sherry Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 2008 5233 5239
6. S. Shu, J.J. Sussman, and A.E. Chang In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagents J Immunother Emphasis Tumor Immunol 14 1993 279 285
7. T. Matsumura, R.A. Krinock, A.E. Chang, and S. Shu Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor Cancer Res 53 1993 4315 4321
8. H. Yoshizawa, A.E. Chang, and S. Shu Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2 J Immunol 147 1991 729 737
9. Q. Li, S.A. Furman, C.R. Bradford, and A.E. Chang Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation Clin Cancer Res 5 1999 461 469
10. Q. Li, B. Yu, A.C. Grover, X. Zeng, and A.E. Chang Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies J Immunother 25 2002 304 313
11. A.E. Chang, A. Aruga, and M.J. Cameron Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2 J Clin Oncol 15 1997 796 807
12. S.L. Meijer, A. Dols, and W.J. Urba Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells J Immunother 25 2002 359 372
13. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V J Immunol Methods 184 1995 39 51
14. D.H. Lynch, and R.E. Miller Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo J Exp Med 179 1994 31 42
15. J.R. Ostberg, R.K. Barth, and J.G. Frelinger The Roman god Janus: a paradigm for the function of CD43 Immunol Today 19 1998 546 550
16. K. Sakuishi, L. Apetoh, J.M. Sullivan, B.R. Blazar, V.K. Kuchroo, and A.C. Anderson Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity J Exp Med 207 2010 2187 2194
17. K.M. van Pul, R.J. Vuylsteke, H. Bril, H.B. Stockmann, and T.D. de Gruijl Feasibility of flowcytometric quantitation of immune effector cell subsets in the sentinel lymph node of the breast after cryopreservation J Immunol Methods 375 2012 189 195
18. L. Tramsen, U. Koehl, and T. Tonn Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy Bone Marrow Transplant 43 2009 13 19
19. L.X. Wang, W.X. Huang, and H. Graor Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells J Transl Med 2 2004 41
20. H. Kagamu, and S. Shu Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes J Immunol 160 1998 3444 3452
21. N.N. Hunder, H. Wallen, and J. Cao Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1 N Engl J Med 358 2008 2698 2703
22. P.A. Cohen, L. Peng, G.E. Plautz, J.A. Kim, D.E. Weng, and S. Shu CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection Crit Rev Immunol 20 2000 17 56
23. A. Aruga, E. Aruga, M.J. Cameron, and A.E. Chang Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression J Leukoc Biol 61 1997 507 516
24. W.C. To, B.G. Wood, and J.C. Krauss Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study Arch Otolaryngol Head Neck Surg 126 2000 1225 1231